US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

261.30

-4.7000-1.77%

Post-market: 261.300.00000.00%19:58 EDT

Volume:227.38K

Turnover:60.97M

Market Cap:489.80M

PE:- -

High:278.96

Open:273.29

Low:261.30

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:12.13%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Mothers Facing Layoffs During Maternity Leave: It's Legal and More Common Than You Think

Worldwide Healthcare Trust Tightens Capital Base With Share Buyback

Health Care Roundup: Market Talk

HCA Healthcare's Reported Layoffs Consistent With Management's Resiliency Initiatives, RBC Says

MT Newswires Live

Definitive Healthcare Gets Acquisition Interest from Advent International

Definitive Healthcare confirms going-private proposal from Advent International

Datametrex to Exit Healthcare Clinics and Double Down on AI and Patent Licensing

Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)

Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds

Definitive Healthcare Appoints Clay Ritchey as CEO

Health Care Select Sector SPDR: Pivot points

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference

Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)

uniQure submits biologics license application to FDA for ifezuntirgene inilparvo

Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Hybio Pharmaceutical Co.,Ltd. (300199.SZ) Pingshan Branch Passes US FDA On-Site Inspection

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Market Closed","change":-4.7,"latestTime":"09-11 16:00:00 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60970299.293749996,"amplitude":0.066396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":265.381,"aum":497453688.27,"dividendRate":0.003844,"bidAskSpread":0.003628,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"eps":0,"divideRate":0.003844,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169327195","title":"Mothers Facing Layoffs During Maternity Leave: It's Legal and More Common Than You Think","url":"https://stock-news.laohu8.com/highlight/detail?id=1169327195","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169327195?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:00","pubTimestamp":1788368435,"startTime":"0","endTime":"0","summary":"Losing a job is never well-timed. Losing one while caring for a newborn is especially brutal. Jess Mayhew was sitting on her couch at home with her newborn son beside her when she received the call...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4194","BK4585","DEI","LABU","BK4581","XLV","BK4223","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843990","title":"Worldwide Healthcare Trust Tightens Capital Base With Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843990","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843990?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:47","pubTimestamp":1788367644,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an announcement. Worldwide Healthcare Trust PLC, a specialist investment trust targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","LU0128526141.USD","HCSG","LU0029874061.USD","BK4581","XLV","BK4588","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844843","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844843","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:20","pubTimestamp":1788366000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0621 ET - EssilorLuxottica remains on a strong track after a sol","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XBI","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664084870","title":"HCA Healthcare's Reported Layoffs Consistent With Management's Resiliency Initiatives, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664084870","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664084870?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:16","pubTimestamp":1788365763,"startTime":"0","endTime":"0","summary":"HCA Healthcare's  reported job cuts are consistent with the enhanced resiliency initiatives that management has been indicating, RBC Capital Markets said in a note Tuesday.HCA confirmed the layoffs across corporate and support functions, citing ongoing shifts in healthcare policy, rising uninsured patient volumes, and cost pressures, RBC said.The investment bank adjusted its outlook to reflect greater resiliency benefits in Q4, as well as management's prior commentary pointing to more difficult year-over-year volume comparisons in Q3 and easier comparisons in Q4.RBC lowered its Q3 EBITDA estimate to $3.635 billion from $3.859 billion and raised its Q4 EBITDA estimate to $4.284 billion from $4.064 billion. Its full-year EBITDA estimate remains unchanged at $15.749 billion.RBC kept an outperform rating on HCA Healthcare with a price target of $435.Price: 411.30, Change: -2.28, Percent Change: -0.55","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0187121727.USD","LU1084165304.USD","LU0433182093.SGD","LU0882574055.USD","LU1201861249.SGD","LABU","LU1261432733.SGD","BK4504","LU2244417387.USD","LU1267930490.SGD","LU1267930573.SGD","XLV","LU0648001328.SGD","SG9999014021.USD","SG9999014005.SGD","LU0985489474.SGD","LU0211327993.USD","LU0980610538.SGD","LU0130102774.USD","LU1150488218.USD","LU1119994496.HKD","SG9999014013.SGD","LU0068578508.USD","LU0128525929.USD","LU2355687059.USD","IHF","LU0310799852.SGD","LU0203347892.USD","SG9999014039.USD","BK4588","LU0708994859.HKD","LU1489326972.SGD","LU0868494617.USD","BK4185","LU1150488135.SGD","LU0310800379.SGD","IE00B3S45H60.SGD","LU0114720955.EUR","LU0203345920.USD","BK4585","XBI","IE00B775SV38.USD","HCA","LU0878866978.SGD","LU0211328371.USD","BK4581","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812985","title":"Definitive Healthcare Gets Acquisition Interest from Advent International","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812985","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812985?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:29","pubTimestamp":1788355740,"startTime":"0","endTime":"0","summary":"Definitive Healthcare said it has received a notice of interest from Advent International to acquire the company for $1.02 a share.Advent, a private-equity firm, would pay in all cash and would bring the healthcare market data provider private, per the non-binding letter.Shares of Definitive Healthcare jumped 14% to $1.03 in premarket trading.Definitive Healthcare said it has formed a special committee composed of independent directors to take actions with respect to a potential deal with Advent.The company doesn't plan to disclose any further updates about the deal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4167","XBI","XLV","LABU","BK4585","DH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812156","title":"Definitive Healthcare confirms going-private proposal from Advent International","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812156","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812156?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:25","pubTimestamp":1788355516,"startTime":"0","endTime":"0","summary":"The special committee of the board of directors of Definitive Healthcare (DH) announced that it has received a non-binding indication of interest f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-confirms-going-private-proposal-from-advent-international-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-confirms-going-private-proposal-from-advent-international-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4167","BK4581","LABU","XBI","XLV","DH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664481233","title":"Datametrex to Exit Healthcare Clinics and Double Down on AI and Patent Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664481233","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664481233?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:13","pubTimestamp":1788354831,"startTime":"0","endTime":"0","summary":"Datametrex AI ( ($TSE:DM) ) has issued an announcement. Datametrex AI Limited has begun winding down its healthcare operations, including multi-dis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/datametrex-to-exit-healthcare-clinics-and-double-down-on-ai-and-patent-licensing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/datametrex-to-exit-healthcare-clinics-and-double-down-on-ai-and-patent-licensing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","BK4581","XLV","AIPO","BK4585","VHT","NOBL","IXJ","TCAF","QTOC","BK4588","LU0029874061.USD","XBI","VTHR","LABU","LU0128526141.USD","CGCV","HCSG","BK4550","ARTY","BK4137","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281410","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281410?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:50","pubTimestamp":1788353406,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on United Therapeutics (UTHR) and Medtronic (MDT). United Therapeuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-united-therapeutics-uthr-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-united-therapeutics-uthr-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B42XCP33.USD","LU0211326755.USD","LU1116320737.USD","LU0265550946.USD","LU1244550221.USD","LU1244550494.USD","BK4566","LU1057294990.SGD","BK4137","LABU","LU1116320901.HKD","LU1244550577.SGD","LU1506573853.SGD","LU1989764664.SGD","LU2468319806.SGD","XBI","BK4581","LU0496365809.HKD","LU0072461881.USD","LU2023251221.USD","IE00BQXX3D17.EUR","LU0208291251.USD","IE000M9KFDE8.USD","LU2089284900.SGD","IE00BQXX3F31.USD","BK4532","LU0029874061.USD","LU2271345857.HKD","LU0432979614.USD","LU1989771016.USD","LU2028103732.USD","HCSG","MDT","LU1291159041.SGD","XLV","IE00BVYPNW00.USD","LU0265550359.USD","LU1061106388.HKD","LU2111349929.HKD","IE00B3PB1722.GBP","LU0320765489.SGD","BK4139","IE00B3T34201.USD","LU0070302665.USD","LU0211331839.USD","UTHR","BK4585","IE00BVYPNV92.GBP","LU0976567544.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814489","title":"Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814489","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814489?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:45","pubTimestamp":1788353109,"startTime":"0","endTime":"0","summary":"Definitive Healthcare (DH) announced that its board of directors has appointed Clay Ritchey as the company’s next CEO and as a member of the board ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-ceo-kevin-coop-departs-clay-ritchey-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definitive-healthcare-ceo-kevin-coop-departs-clay-ritchey-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","DH","BK4167","XBI","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981121","title":"Definitive Healthcare Appoints Clay Ritchey as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981121","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981121?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355135/0/en/definitive-healthcare-appoints-clay-ritchey-as-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","NOBL","BK4167","XBI","TCAF","VHT","BK4588","LABU","CGCV","DH","IXJ","BK4550","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811085","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811085?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:25","pubTimestamp":1788351957,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.60, Pivot Low: $170.10. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","XBI","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664112138","title":"SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664112138","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664112138?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:17","pubTimestamp":1788351420,"startTime":"0","endTime":"0","summary":"This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility among key U.S. federal stakeholders, reinforce the clinical and publichealth importance of advancing n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355122/0/en/scisparc-subsidiary-neurothera-labs-pursues-fda-orphan-drug-designation-for-adult-tourette-syndrome-drug-engages-government-and-public-affairs-firm-rk-strategies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819046","title":"Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819046","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819046?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355075/0/en/acrivon-therapeutics-to-present-at-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","XLV","LENZ","HCSG","BK4137","BK4585","LABU","XBI","BK4139","LU0128526141.USD","BK4588","BK4539","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819044","title":"Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819044?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355100/0/en/design-therapeutics-to-participate-in-2026-cantor-fitzgerald-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0029874061.USD","DSGN","BK4505","XLV","BK4139","XBI","BK4581","BK4585","HCSG","LABU","BK4539","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664118518","title":"Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664118518","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664118518?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355096/0/en/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","BK4581","LU0029874061.USD","BK4082","BK4585","BK4137","LABU","XLV","LU0128526141.USD","XBI","BK4588","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819473","title":"Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819473?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:50","pubTimestamp":1788349806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on SpaceX (SPCX) and HCA Healthcare (HCA) with bullish sentimen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0068578508.USD","SPAX","LOFD","LU1267930490.SGD","XBI","LABU","DXYZ","ORBX","WARP","LOFF","LU2290526834.HKD","HCA","BK4504","SPCU","LU1150488218.USD","SPCX","SPCM","LU1489326972.SGD","BK4588","SPCF","LU0878866978.SGD","IHF","YSPC","LU0130102774.USD","WSPC","ELOL","SPCQ","LU0708994859.HKD","SG9999014013.SGD","BK4089","SPCG","SSPC","XOVR","LU1861220033.SGD","NA","XOVL","SPAL","LU1261432733.SGD","XLV","BK4615","LU2360107168.USD","MARS","SPCH","LU0980610538.SGD","BK4585","SNK","UFO","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819178","title":"uniQure submits biologics license application to FDA for ifezuntirgene inilparvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819178","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819178?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:45","pubTimestamp":1788349557,"startTime":"0","endTime":"0","summary":"uniQure (QURE) announced the submission of a biologics license application, or BLA, to the FDA for the accelerated approval of ifezuntirgene inilpa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-submits-biologics-license-application-to-fda-for-ifezuntirgene-inilparvo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-submits-biologics-license-application-to-fda-for-ifezuntirgene-inilparvo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","QURE","BK4588","LABU","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664554819","title":"Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664554819","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664554819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"WAYNE, Pa., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commerciali","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355020/0/en/palvella-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4137","BK4588","PVLA","LU0029874061.USD","BK4581","XLV","BK4139","LU0128526141.USD","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150698","title":"uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150698","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150698?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347100,"startTime":"0","endTime":"0","summary":"~ Company also announces the submission of a Marketing Authorisation Application for ifezuntirgene inilparvovec in the U.K. ~ ~ Both submissions are supported by the three-year data analysis from the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354993/0/en/uniqure-announces-submission-of-biologics-license-application-for-ifezuntirgene-inilparvovec-amt-130-in-huntington-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRED","TRUR","ICF","AVRE","DFGR","SPRE","VNQ","XLRE","HELS","BK4534","BK4084","LU0109394709.USD","LU0320765992.SGD","DTCR","LU0889565916.HKD","SRVR","AMT","BK4588","BK4215","BYRE","REAI","DTRE","WTRE","BK4219","BK4139","BK4554","IDGT","BK4585","MAA","FREL","BK4581","GNOM","LABU","PSR","URE","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169516845","title":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) Pingshan Branch Passes US FDA On-Site Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1169516845","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169516845?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:56","pubTimestamp":1788346575,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) has announced that its Pingshan branch underwent a routine Current Good Manufacturing Practice (cGMP) inspection by the U.S. Food and Drug Administration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK0188","BK0077","BK4588","LABU","BK0239","BK0028","300199","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":15,"totalSize":407,"code":"91000000","status":"200"}]}}